Back to Search
Start Over
Kitov Expands Planned Phase 1|2 Clinical Trial of CM24 in Non-Small Cell Lung Cancer with New Cohort to Evaluate CM24 in Patients with Pancreatic Cancer Conducted with Bristol Myers Squibb
- Source :
- Legal Monitor Worldwide. November 10, 2020
- Publication Year :
- 2020
-
Abstract
- (GlobeNewswire) - Kitov Pharma Ltd. (Kitov) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that the company and Bristol Myers [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Legal Monitor Worldwide
- Publication Type :
- News
- Accession number :
- edsgcl.641072718